Moors & Cabot’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-56,500
| Closed | -$50.1K | – | 899 |
|
|
2022
Q4 | $50.1K | Sell |
56,500
-2,000
| -3% | -$1.77K | ﹤0.01% | 815 |
|
|
2022
Q3 | $92K | Sell |
58,500
-3,000
| -5% | -$4.72K | 0.01% | 768 |
|
|
2022
Q2 | $124K | Sell |
61,500
-1,000
| -2% | -$2.02K | 0.01% | 742 |
|
|
2022
Q1 | $146K | Buy |
62,500
+50,750
| +432% | +$119K | 0.01% | 796 |
|
|
2021
Q4 | $55K | Buy |
+11,750
| New | +$55K | ﹤0.01% | 837 |
|
|
2020
Q4 | – | Sell |
-17,650
| Closed | -$197K | – | 745 |
|
|
2020
Q3 | $197K | Buy |
+17,650
| New | +$197K | 0.02% | 600 |
|